| DWEQ is an actively managed ETF that follows a quantitative proprietary model based on momentum indicators and seeks long-term capital appreciation. |
FUND BASICS
| Category |
US Equities |
| Fund Sponsor |
AdvisorShares |
| Website |
advisorshares.com |
| Inception date |
Dec 26, 2019 |
| Assets (mns) |
$0 |
| Currency |
USD |
| Expense ratio |
0 bp |
| Distributions |
Annually |
FUND STRUCTURE
| Regulation |
Open-Ended Fund |
| Custodian |
|
| Weighting |
Proprietary |
| Index replication |
|
| Uses derivatives |
No |
| Options available |
No |
CONSTITUENT BREAKDOWN
| No. of constituents |
40 |
| Wgt avg mkt cap (mns) |
$55,613 |
| Large cap (>$10bn) |
70.1% |
| Mid cap ($2-10bn) |
29.9% |
| Small cap (<$2bn) |
0.0% |
| Developed mkts |
100.0% |
| Emerging mkts |
0.0% |
TOP TEN HOLDINGS
| IDEXX LABORATORIES INC |
3.4 % |
| REGENERON PHARMACEUTICALS |
3.2 % |
| SAREPTA THERAPEUTICS INC |
3.1 % |
| CHEMED CORP |
3.1 % |
| THERMO FISHER SCIENTIFIC INC |
3.0 % |
| METTLER-TOLEDO INTERNATIONAL |
3.0 % |
| MARATHON PETROLEUM |
2.8 % |
| LANTHEUS HOLDINGS INC |
2.8 % |
| MCKESSON CORP |
2.8 % |
| ANTERO MIDSTREAM PARTNERS LP |
2.7 % |
Total |
29.8 % |
TOP COUNTRY EXPOSURE
 |
UNITED STATES |
96.7 % |
 |
IRELAND |
2.6 % |
Standardized Annual Returns (thru August 31)
| Year-to-date |
1 year |
5 years |
10 years |
Since Incep. |
| -- |
-- |
-- |
-- |
0.0% |
Market Correlations
| versus... |
Beta |
R-squared |
| S&P500 |
0.87 |
65% |
| MSCI EAFE |
0.73 |
47% |
| MSCI Emg. Mkts. |
0.57 |
26% |
Technical Indicators
| Recent close |
$0.00 |
| 30d moving avg. |
$0.00 |
| Annualized volatility |
19.8% |
| Short interest (ETF) |
0.0% |
| Short interest (Underlying) |
2.9% |
| Relative strength (RSI) |
|
Liquidity measures
| Avg. volume (thou.) |
0 |
| Turnover |
0.0% |
| Bid/Ask (% of price) |
0.29% |
| ADV underlying (mns) |
$6,527 |
 |
There were no matches found with other funds under coverage. |
Content on this tab for subscribers only**
| |
2018 |
2019 |
2020 |
2021 |
2022 |
2023E |
2024E |
| Sales per share |
** |
** |
** |
** |
** |
** |
** |
| Earnings per share |
** |
** |
** |
** |
** |
** |
** |
Dividends per share  |
** |
** |
** |
** |
** |
** |
** |
| Book value per share |
** |
** |
** |
** |
** |
** |
** |
| Sales per share growth |
|
**% |
**% |
**% |
**% |
**% |
**% |
| EPS growth |
|
**% |
**% |
**% |
**% |
**% |
**% |
| Sales per share growth |
|
**% |
**% |
**% |
**% |
**% |
**% |
| EPS growth |
|
**% |
**% |
**% |
**% |
**% |
**% |
| Long term EPS growth est. |
**% |
|
Debt-to-equity |
**x |
| Asset turnover |
**% |
|
Assets-to-equity |
**x |
Revision activity*
|
| *Six months ago = 100 |
Compound annual growth rates
|
Content on this tab for subscribers only
| |
2022 |
2023E |
2024E |
| Price-to-sales |
** |
** |
** |
| Price-to-earnings |
** |
** |
** |
| Price-to-cash flow |
** |
** |
** |
| Price-to-growth |
** |
** |
** |
| Price-to-book value |
** |
** |
** |
| Yield |
** |
** |
** |
AVOID |
| Not worthwhile for most investors. A rating of AVOID is assigned to ETFs with ALTAR Scores in the lowest quintile (the bottom 20%) of their category. Often, funds in this category consist of stocks with little if any history or expectation of profitability, and as a result our fundamentally-driven analysis may not be relevant. |
| Calculation of ALTAR Score™ |
| Avg. Return on Equity |
18.4 |
% |
| Divided by: Fwd. P/BV |
0.0 |
x |
| Less: Expense ratio |
0 |
bp |
| Equals: ALTAR Score |
0.0 |
% |
|
| More information on ALTAR Score™ |
|
|
|
COMPOSITE
RATING |
1.45 |
CATEGORY
AVERAGE |
1.50 |
| |
The composite rating is a weighted average of analysts'
consensus recommendations for individual ETF constituents, based on the following scale:
BUY = 1; OVERWEIGHT = 1.5, HOLD = 2; UNDERWEIGHT = 2.5; and SELL = 3.
Readers are cautioned that because analyst ratings tend to be inflated, the composite score may be
more useful as a relative measure of sentiment between funds rather than as a stand-alone recommendation.
|
|
|
|
Fundamentals